Table 3:

Predictors of severe outcomes among patients with CDI diagnosis*

CovariateAdjusted OR (95% CI)
Age, yr (Ref: 18–69 yr)
 70–791.52 (1.22 to 1.89)
 ≥ 802.44 (2.02 to 2.94)
Female sex (v. male)0.92 (0.79 to 1.08)
SEFI1.11 (1.02 to 1.20)
CCI (Ref: 0)§
 11.88 (1.46 to 2.43)
 22.06 (1.59 to 2.66)
 ≥ 32.55 (1.97 to 3.30)
Diabetes (v. none)0.98 (0.81 to 1.18)
Renal disease (v. none)1.65 (1.34 to 2.02)
IBD (v. none)0.82 (0.45 to 1.49)
Ambulatory care visits in prior year (v. most)
 Least0.69 (0.52 to 0.92)
 Quartile 20.80 (0.64 to 1.01)
 Quartile 30.93 (0.76 to 1.13)
CDI subtype (v. community-associated)
 HCF-onset HCF-associated2.56 (2.02 to 3.25)
 Community-onset HCF-associated1.32 (0.99 to 1.77)
 Indeterminate1.02 (0.71 to 1.49)
Recurrent CDI (v. incident CDI)0.64 (0.52 to 0.79)
  • Note: CDI = Clostridioides difficile infection, CCI = Charlson Comorbidity Index, CI = confidence interval, HCF = health care facility, IBD = inflammatory bowel disease, OR = odds ratio, SEFI = Socioeconomic Factor Index.

  • * 831 severe outcomes among 6154 patients diagnosed with CDI.

  • The ORs were adjusted for all the factors listed in the table.

  • SEFI was handled as a continuous variable.

  • § Renal disease and diabetes omitted from CCI calculation.

  • In the subgroup analysis of those with HCF-onset HCF-associated CDI, longer stay in hospital (> 17 days) before CDI onset was associated with increased risk of severe outcomes (OR 1.36, 95% CI 1.11 to 1.68); 563 severe outcomes among 2568 individuals.